サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1785939

心臓人工知能によるモニタリングと診断の世界市場

Cardiac Artificial Intelligence Monitoring and Diagnostics

出版日
ページ情報
英文 202 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=148.84円
心臓人工知能によるモニタリングと診断の世界市場
出版日: 2025年08月07日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 202 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

心臓人工知能によるモニタリングと診断の世界市場は2030年までに57億米ドルに達する

2024年に13億米ドルと推定される心臓人工知能によるモニタリングと診断の世界市場は、分析期間2024-2030年にCAGR 27.5％で成長し、2030年には57億米ドルに達すると予測されます。本レポートで分析したセグメントの1つである心臓AIモニタリング＆診断ハードウェアは、CAGR 30.5％を記録し、分析期間終了までに33億米ドルに達すると予測されます。心臓AIモニタリング＆診断ソフトウェア分野の成長率は、分析期間でCAGR 25.0％と推定されます。

米国市場は3億4,660万米ドルと推定、中国はCAGR25.9％で成長予測

米国の心臓人工知能によるモニタリングと診断市場は、2024年に3億4,660万米ドルと推定されます。世界第2位の経済大国である中国は、分析期間2024-2030年のCAGR 25.9%を牽引し、2030年までに8億5,040万米ドルの市場規模に達すると予測されています。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ25.5％と23.4％と予測されています。欧州では、ドイツがCAGR約18.7%で成長すると予測されています。

世界の心臓人工知能によるモニタリングと診断市場- 主要動向と促進要因のまとめ

なぜ心臓人工知能によるモニタリングと診断の需要が増加しているのか？

心臓人工知能によるモニタリングと診断の需要は、心血管疾患の有病率の増加、早期かつ正確な検出の必要性、AI主導型ヘルスケアソリューションの進歩により高まっています。冠動脈疾患、心不全、不整脈などの心臓疾患は、依然として世界の死亡原因のトップです。従来の診断方法は、効果的ではあるもの、多くの場合、時間のかかる解釈を必要とし、人為的ミスが起こりやすいです。AIを搭載したモニタリングシステムと診断ツールは、心臓の健康状態について、より迅速かつ正確でリアルタイムの洞察を提供することで、心血管治療に変革をもたらしつつあります。

ウェアラブル・ヘルス・テクノロジー、遠隔患者モニタリング、AI支援画像診断の台頭により、心臓診断がより身近で積極的なものとなっています。AIを活用した心電図の解釈、心不全の予測分析、不整脈の自動検出は、医療提供者の負担を軽減しながら、臨床医が十分な情報に基づいた判断を下すのに役立っています。さらに、テレヘルスやデジタルヘルスプラットフォームにAIを統合することで、特にハイリスク患者への早期介入が可能になり、入院を減らし、患者の転帰を改善することができます。ヘルスケアシステムが予知的・予防的心臓病学にシフトするにつれて、AI主導型心臓診断の採用は拡大すると予想されます。

技術の進歩は心臓AIモニタリングと診断をどのように改善しているのか？

人工知能、ディープラーニング、ウェアラブルセンサー技術の革新により、心臓モニタリングと診断の精度、効率、アクセシビリティが向上しています。最も重要な進歩の1つは、心房細動、心室頻拍、心筋梗塞などの複雑な心疾患を高い精度で検出できるAI強化心電図（ECG）の開発です。AIを搭載したECGアルゴリズムは、膨大な量のデータをリアルタイムで分析し、診断ミスを減らし、早期発見率を向上させることができます。

もう1つの大きなブレークスルーは、心エコー、心臓MRI、CT血管造影などの心血管画像診断におけるAIの統合です。AIを活用した画像診断ソリューションは、放射線科医や心臓専門医が異常を特定し、心臓機能を定量化し、冠動脈疾患をより効率的に評価できるよう支援します。さらに、スマートウォッチやバイオセンサーなどのウェアラブルAI搭載心臓モニターは、継続的なリアルタイムの心臓健康モニタリングを提供し、症状が重篤化する前に潜在的なリスクをユーザーやヘルスケアプロバイダーに警告します。機械学習モデルもまた、心臓病の進行を予測し、患者固有のデータに基づいて治療計画をパーソナライズするために開発されています。AI技術が進化し続けるにつれて、心臓医療におけるAIの役割はさらに顕著になり、正確性、効率性、疾患の早期発見が向上します。

心臓AIモニタリング・診断業界の成長を牽引する市場動向は？

遠隔医療と遠隔患者モニタリングにおけるAIの採用の増加は、心臓人工知能市場を形成する最も影響力のある動向の1つです。バーチャル・ヘルスケアの台頭により、AIを搭載した心臓モニタリング・デバイスは、自宅での継続的な心臓の健康追跡を可能にし、頻繁な病院受診の必要性を減らしています。この動向は、リアルタイムのAI分析によって、深刻な合併症につながる前に不整脈を検出することができるため、慢性心疾患やハイリスク患者の管理にとって特に重要です。

市場成長に影響を与えるもう1つの主要動向は、個別化医療におけるAIの拡大です。AI主導のアナリティクスは、個々の患者データに基づいて治療計画を調整し、心臓病患者の転帰を改善するために利用されています。さらに、製薬会社はAIを活用して心血管治療の創薬を最適化し、AIを心臓治療の広範なエコシステムにさらに統合しようとしています。心臓病学におけるビッグデータの台頭は、クラウドベースのAIソリューションとともに、ヘルスケア専門家間のシームレスなデータ共有とリアルタイムのコラボレーションを可能にし、患者ケアを強化しています。AIによる診断が改善し続ける中、病院のワークフローへの統合が進み、AIを活用した心臓モニタリングが循環器ヘルスケアの標準となりつつあります。

心臓AIモニタリング・診断市場の将来を形作る主な成長促進要因は何か？

心臓人工知能によるモニタリングと診断市場の成長は、心血管疾患有病率の上昇、AIアルゴリズムの進歩、デジタルヘルスインフラの拡大など、いくつかの重要な要因によってもたらされます。主な成長要因の1つは、心臓病の負担増であり、早期発見、予測分析、継続的モニタリングソリューションの必要性を促しています。AI主導の診断ツールは、心臓病の診断に必要な時間を短縮し、迅速な介入と患者の転帰の改善を可能にします。

市場を形成するもう1つの重要な促進要因は、ヘルスケア機関によるAI搭載診断ソリューションの規制承認と採用の増加です。政府や規制機関は、心臓病学におけるAIの可能性を認識しており、AI研究やデジタルヘルスケア政策への投資拡大につながっています。さらに、AI駆動型ウェアラブルの手頃な価格と入手しやすさは、AIの解釈可能性の向上と相まって、心臓モニタリングをより患者にやさしく拡張可能なものにしています。ヘルスケアにおけるAIの統合が加速し続ける中、心臓AIモニタリング・診断市場は大幅な成長を遂げ、世界中の心臓病の検出、予防、管理に革命をもたらすと期待されています。

セグメント

製品タイプ（心臓AIモニタリング・診断ハードウェア、心臓AIモニタリング・診断ソフトウェア、心臓AIモニタリング・診断サービス）、タイプ（心臓診断、心臓モニタリング）、用途（心臓不整脈用途、脳卒中用途、虚血性心疾患用途、狭窄用途、その他用途）、最終用途（病院最終用途、専門クリニック最終用途、診断センター最終用途、その他最終用途）

調査対象企業の例

  • Abbott Laboratories
  • Aidoc Medical Ltd.
  • AliveCor, Inc.
  • Arterys Inc.
  • Boston Scientific Corporation
  • CardiAI
  • Cardio Diagnostics
  • Cardiologs Technologies
  • Cleerly, Inc.
  • DiA Imaging Analysis
  • Eko Health Inc.
  • GE HealthCare Technologies Inc.
  • HeartVista, Inc.
  • Idoven
  • iRhythm Technologies, Inc.
  • Koninklijke Philips N.V.
  • Medtronic plc
  • RSIP Vision
  • Siemens Healthineers AG
  • Tempus AI, Inc.

AIインテグレーション

Global Industry Analystsは、有効な専門家コンテンツとAIツールにより、市場情報と競合情報を変革しています。

Global Industry Analystsは、LLMや業界固有のSLMを照会する一般的な規範に従う代わりに、ビデオ記録、ブログ、検索エンジン調査、膨大な量の企業、製品/サービス、市場データなど、世界中の専門家から収集したコンテンツのリポジトリを構築しました。

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、売上原価（COGS）の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • その他欧州
  • アジア太平洋
  • その他の地域

第4章 競合

目次
Product Code: MCP29823

Global Cardiac Artificial Intelligence Monitoring and Diagnostics Market to Reach US$5.7 Billion by 2030

The global market for Cardiac Artificial Intelligence Monitoring and Diagnostics estimated at US$1.3 Billion in the year 2024, is expected to reach US$5.7 Billion by 2030, growing at a CAGR of 27.5% over the analysis period 2024-2030. Cardiac AI Monitoring & Diagnostics Hardware, one of the segments analyzed in the report, is expected to record a 30.5% CAGR and reach US$3.3 Billion by the end of the analysis period. Growth in the Cardiac AI Monitoring & Diagnostics Software segment is estimated at 25.0% CAGR over the analysis period.

The U.S. Market is Estimated at US$346.6 Million While China is Forecast to Grow at 25.9% CAGR

The Cardiac Artificial Intelligence Monitoring and Diagnostics market in the U.S. is estimated at US$346.6 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$850.4 Million by the year 2030 trailing a CAGR of 25.9% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 25.5% and 23.4% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 18.7% CAGR.

Global Cardiac Artificial Intelligence Monitoring and Diagnostics Market - Key Trends & Drivers Summarized

Why Is the Demand for Cardiac Artificial Intelligence Monitoring and Diagnostics Increasing?

The demand for cardiac artificial intelligence monitoring and diagnostics is rising due to the increasing prevalence of cardiovascular diseases, the need for early and accurate detection, and advancements in AI-driven healthcare solutions. Heart diseases, including coronary artery disease, heart failure, and arrhythmias, remain the leading cause of mortality worldwide. Traditional diagnostic methods, while effective, often require time-consuming interpretation and are prone to human error. AI-powered monitoring systems and diagnostic tools are transforming cardiovascular care by providing faster, more precise, and real-time insights into heart health.

The rise of wearable health technology, remote patient monitoring, and AI-assisted imaging has made cardiac diagnostics more accessible and proactive. AI-powered ECG interpretation, predictive analytics for heart failure, and automated detection of arrhythmias are helping clinicians make informed decisions while reducing the burden on healthcare providers. Additionally, the integration of AI in telehealth and digital health platforms allows for early intervention, particularly in high-risk patients, reducing hospitalizations and improving patient outcomes. As healthcare systems shift towards predictive and preventive cardiology, the adoption of AI-driven cardiac diagnostics is expected to expand.

How Are Technological Advancements Improving Cardiac AI Monitoring and Diagnostics?

Innovations in artificial intelligence, deep learning, and wearable sensor technology are enhancing the accuracy, efficiency, and accessibility of cardiac monitoring and diagnostics. One of the most significant advancements is the development of AI-enhanced electrocardiograms (ECGs) that can detect complex cardiac conditions such as atrial fibrillation, ventricular tachycardia, and myocardial infarctions with high accuracy. AI-powered ECG algorithms can analyze vast amounts of data in real-time, reducing diagnostic errors and improving early detection rates.

Another major breakthrough is the integration of AI in cardiovascular imaging, including echocardiography, cardiac MRI, and CT angiography. AI-driven imaging solutions assist radiologists and cardiologists in identifying abnormalities, quantifying heart function, and assessing coronary artery disease more efficiently. Additionally, wearable AI-powered cardiac monitors, such as smartwatches and biosensors, provide continuous, real-time heart health monitoring, alerting users and healthcare providers to potential risks before symptoms become critical. Machine learning models are also being developed to predict heart disease progression and personalize treatment plans based on patient-specific data. As AI technology continues to evolve, its role in cardiac care will become even more prominent, improving accuracy, efficiency, and early disease detection.

Which Market Trends Are Driving Growth in the Cardiac AI Monitoring and Diagnostics Industry?

The increasing adoption of AI in telemedicine and remote patient monitoring is one of the most influential trends shaping the cardiac artificial intelligence market. With the rise of virtual healthcare, AI-powered cardiac monitoring devices are enabling continuous, at-home heart health tracking, reducing the need for frequent hospital visits. This trend is particularly important for managing chronic heart conditions and high-risk patients, as real-time AI analytics can help detect irregularities before they lead to severe complications.

Another key trend influencing market growth is the expansion of AI in personalized medicine. AI-driven analytics are being used to tailor treatment plans based on individual patient data, improving outcomes for those with heart disease. Additionally, pharmaceutical companies are leveraging AI to optimize drug discovery for cardiovascular treatments, further integrating AI into the broader ecosystem of cardiac care. The rise of big data in cardiology, along with cloud-based AI solutions, is enabling seamless data sharing and real-time collaboration between healthcare professionals, enhancing patient care. As AI-driven diagnostics continue to improve, they are increasingly being integrated into hospital workflows, making AI-powered cardiac monitoring a standard in cardiovascular healthcare.

What Are the Key Growth Drivers Shaping the Future of the Cardiac AI Monitoring and Diagnostics Market?

The growth in the cardiac artificial intelligence monitoring and diagnostics market is driven by several key factors, including rising cardiovascular disease prevalence, advancements in AI algorithms, and the expansion of digital health infrastructure. One of the primary growth drivers is the increasing burden of heart disease, prompting the need for early detection, predictive analytics, and continuous monitoring solutions. AI-driven diagnostic tools reduce the time required for heart disease diagnosis, allowing for faster interventions and improved patient outcomes.

Another crucial driver shaping the market is the increasing regulatory approvals and adoption of AI-powered diagnostic solutions by healthcare institutions. Governments and regulatory bodies are recognizing the potential of AI in cardiology, leading to greater investments in AI research and digital healthcare policies. Additionally, the affordability and accessibility of AI-driven wearables, coupled with improved AI interpretability, are making cardiac monitoring more patient-friendly and scalable. As AI integration in healthcare continues to accelerate, the cardiac AI monitoring and diagnostics market is expected to witness substantial growth, revolutionizing heart disease detection, prevention, and management worldwide.

SCOPE OF STUDY:

The report analyzes the Cardiac Artificial Intelligence Monitoring and Diagnostics market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product Type (Cardiac AI Monitoring and Diagnostics Hardware, Cardiac AI Monitoring and Diagnostics Software, Cardiac AI Monitoring and Diagnostics Services); Type (Cardiac Diagnostics, Cardiac Monitoring); Application (Cardiac Arrhythmias Application, Stroke Application, Ischemic Heart Disease Application, Stenosis Application, Other Applications); End-Use (Hospitals End-Use, Specialty Clinics End-Use, Diagnostic Centers End-Use, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 34 Featured) -

  • Abbott Laboratories
  • Aidoc Medical Ltd.
  • AliveCor, Inc.
  • Arterys Inc.
  • Boston Scientific Corporation
  • CardiAI
  • Cardio Diagnostics
  • Cardiologs Technologies
  • Cleerly, Inc.
  • DiA Imaging Analysis
  • Eko Health Inc.
  • GE HealthCare Technologies Inc.
  • HeartVista, Inc.
  • Idoven
  • iRhythm Technologies, Inc.
  • Koninklijke Philips N.V.
  • Medtronic plc
  • RSIP Vision
  • Siemens Healthineers AG
  • Tempus AI, Inc.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Cardiac Artificial Intelligence Monitoring and Diagnostics - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Global Cardiovascular Disease Burden Throws the Spotlight on AI-Powered Cardiac Monitoring Systems
    • Integration of AI in ECG, Imaging, and Wearables Propels Growth in Real-Time Diagnostic Capabilities
    • Early Detection and Risk Stratification Capabilities Expand the Addressable Market for AI Cardiac Tools
    • AI Algorithms for Arrhythmia, Heart Failure, and Ischemia Enhance Diagnostic Precision and Speed
    • Telecardiology Adoption Accelerates Demand for Remote AI-Driven Monitoring Platforms
    • Healthcare Shift Toward Predictive Analytics Strengthens the Business Case for AI Diagnostics
    • Wearable and Ambulatory Monitoring Devices Integrated with AI Spur Out-of-Hospital Cardiac Care Growth
    • Smart Hospitals and Digital Health Ecosystems Fuel Demand for AI-Based Clinical Decision Support Tools
    • AI-Powered Imaging Interpretation Drives Efficiency in Echocardiography and Cardiac MRI/CT Analysis
    • Regulatory Approvals of AI Software-as-Medical-Device (SaMD) Create New Commercial Pathways
    • Cardiology Workflow Optimization through AI Reduces Diagnostic Time and Clinical Burden
    • Collaborations Between MedTech and AI Startups Accelerate Product Innovation and Market Entry
    • Growing Role of AI in Population Health Management and Preventive Cardiology Supports Market Adoption
    • AI Model Transparency, Validation, and Explainability Become Critical in Regulatory and Clinical Acceptance
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Cardiac Artificial Intelligence Monitoring and Diagnostics Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Cardiac Artificial Intelligence Monitoring and Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 3: World 6-Year Perspective for Cardiac Artificial Intelligence Monitoring and Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2025 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Cardiac AI Monitoring & Diagnostics Hardware by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 5: World 6-Year Perspective for Cardiac AI Monitoring & Diagnostics Hardware by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 6: World Recent Past, Current & Future Analysis for Cardiac AI Monitoring & Diagnostics Software by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 7: World 6-Year Perspective for Cardiac AI Monitoring & Diagnostics Software by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Cardiac AI Monitoring & Diagnostics Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 9: World 6-Year Perspective for Cardiac AI Monitoring & Diagnostics Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 11: World 6-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 12: World Recent Past, Current & Future Analysis for Cardiac Arrhythmias Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 13: World 6-Year Perspective for Cardiac Arrhythmias Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Stroke Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 15: World 6-Year Perspective for Stroke Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Ischemic Heart Disease Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 17: World 6-Year Perspective for Ischemic Heart Disease Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 18: World Recent Past, Current & Future Analysis for Stenosis Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 19: World 6-Year Perspective for Stenosis Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 21: World 6-Year Perspective for Hospitals End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 22: World Recent Past, Current & Future Analysis for Specialty Clinics End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 23: World 6-Year Perspective for Specialty Clinics End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 24: World Recent Past, Current & Future Analysis for Diagnostic Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 25: World 6-Year Perspective for Diagnostic Centers End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 27: World 6-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 28: World Recent Past, Current & Future Analysis for Cardiac Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 29: World 6-Year Perspective for Cardiac Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 30: World Recent Past, Current & Future Analysis for Cardiac Monitoring by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 31: World 6-Year Perspective for Cardiac Monitoring by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Cardiac Artificial Intelligence Monitoring and Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 32: USA Recent Past, Current & Future Analysis for Cardiac Artificial Intelligence Monitoring and Diagnostics by Product Type - Cardiac AI Monitoring & Diagnostics Hardware, Cardiac AI Monitoring & Diagnostics Software and Cardiac AI Monitoring & Diagnostics Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 33: USA 6-Year Perspective for Cardiac Artificial Intelligence Monitoring and Diagnostics by Product Type - Percentage Breakdown of Value Sales for Cardiac AI Monitoring & Diagnostics Hardware, Cardiac AI Monitoring & Diagnostics Software and Cardiac AI Monitoring & Diagnostics Services for the Years 2025 & 2030
    • TABLE 34: USA Recent Past, Current & Future Analysis for Cardiac Artificial Intelligence Monitoring and Diagnostics by Application - Other Applications, Cardiac Arrhythmias Application, Stroke Application, Ischemic Heart Disease Application and Stenosis Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 35: USA 6-Year Perspective for Cardiac Artificial Intelligence Monitoring and Diagnostics by Application - Percentage Breakdown of Value Sales for Other Applications, Cardiac Arrhythmias Application, Stroke Application, Ischemic Heart Disease Application and Stenosis Application for the Years 2025 & 2030
    • TABLE 36: USA Recent Past, Current & Future Analysis for Cardiac Artificial Intelligence Monitoring and Diagnostics by End-Use - Hospitals End-Use, Specialty Clinics End-Use, Diagnostic Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 37: USA 6-Year Perspective for Cardiac Artificial Intelligence Monitoring and Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use, Diagnostic Centers End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 38: USA Recent Past, Current & Future Analysis for Cardiac Artificial Intelligence Monitoring and Diagnostics by Type - Cardiac Diagnostics and Cardiac Monitoring - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: USA 6-Year Perspective for Cardiac Artificial Intelligence Monitoring and Diagnostics by Type - Percentage Breakdown of Value Sales for Cardiac Diagnostics and Cardiac Monitoring for the Years 2025 & 2030
  • CANADA
    • TABLE 40: Canada Recent Past, Current & Future Analysis for Cardiac Artificial Intelligence Monitoring and Diagnostics by Product Type - Cardiac AI Monitoring & Diagnostics Hardware, Cardiac AI Monitoring & Diagnostics Software and Cardiac AI Monitoring & Diagnostics Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 41: Canada 6-Year Perspective for Cardiac Artificial Intelligence Monitoring and Diagnostics by Product Type - Percentage Breakdown of Value Sales for Cardiac AI Monitoring & Diagnostics Hardware, Cardiac AI Monitoring & Diagnostics Software and Cardiac AI Monitoring & Diagnostics Services for the Years 2025 & 2030
    • TABLE 42: Canada Recent Past, Current & Future Analysis for Cardiac Artificial Intelligence Monitoring and Diagnostics by Application - Other Applications, Cardiac Arrhythmias Application, Stroke Application, Ischemic Heart Disease Application and Stenosis Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 43: Canada 6-Year Perspective for Cardiac Artificial Intelligence Monitoring and Diagnostics by Application - Percentage Breakdown of Value Sales for Other Applications, Cardiac Arrhythmias Application, Stroke Application, Ischemic Heart Disease Application and Stenosis Application for the Years 2025 & 2030
    • TABLE 44: Canada Recent Past, Current & Future Analysis for Cardiac Artificial Intelligence Monitoring and Diagnostics by End-Use - Hospitals End-Use, Specialty Clinics End-Use, Diagnostic Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Canada 6-Year Perspective for Cardiac Artificial Intelligence Monitoring and Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use, Diagnostic Centers End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 46: Canada Recent Past, Current & Future Analysis for Cardiac Artificial Intelligence Monitoring and Diagnostics by Type - Cardiac Diagnostics and Cardiac Monitoring - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 47: Canada 6-Year Perspective for Cardiac Artificial Intelligence Monitoring and Diagnostics by Type - Percentage Breakdown of Value Sales for Cardiac Diagnostics and Cardiac Monitoring for the Years 2025 & 2030
  • JAPAN
    • Cardiac Artificial Intelligence Monitoring and Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 48: Japan Recent Past, Current & Future Analysis for Cardiac Artificial Intelligence Monitoring and Diagnostics by Product Type - Cardiac AI Monitoring & Diagnostics Hardware, Cardiac AI Monitoring & Diagnostics Software and Cardiac AI Monitoring & Diagnostics Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 49: Japan 6-Year Perspective for Cardiac Artificial Intelligence Monitoring and Diagnostics by Product Type - Percentage Breakdown of Value Sales for Cardiac AI Monitoring & Diagnostics Hardware, Cardiac AI Monitoring & Diagnostics Software and Cardiac AI Monitoring & Diagnostics Services for the Years 2025 & 2030
    • TABLE 50: Japan Recent Past, Current & Future Analysis for Cardiac Artificial Intelligence Monitoring and Diagnostics by Application - Other Applications, Cardiac Arrhythmias Application, Stroke Application, Ischemic Heart Disease Application and Stenosis Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Japan 6-Year Perspective for Cardiac Artificial Intelligence Monitoring and Diagnostics by Application - Percentage Breakdown of Value Sales for Other Applications, Cardiac Arrhythmias Application, Stroke Application, Ischemic Heart Disease Application and Stenosis Application for the Years 2025 & 2030
    • TABLE 52: Japan Recent Past, Current & Future Analysis for Cardiac Artificial Intelligence Monitoring and Diagnostics by End-Use - Hospitals End-Use, Specialty Clinics End-Use, Diagnostic Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 53: Japan 6-Year Perspective for Cardiac Artificial Intelligence Monitoring and Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use, Diagnostic Centers End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 54: Japan Recent Past, Current & Future Analysis for Cardiac Artificial Intelligence Monitoring and Diagnostics by Type - Cardiac Diagnostics and Cardiac Monitoring - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 55: Japan 6-Year Perspective for Cardiac Artificial Intelligence Monitoring and Diagnostics by Type - Percentage Breakdown of Value Sales for Cardiac Diagnostics and Cardiac Monitoring for the Years 2025 & 2030
  • CHINA
    • Cardiac Artificial Intelligence Monitoring and Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 56: China Recent Past, Current & Future Analysis for Cardiac Artificial Intelligence Monitoring and Diagnostics by Product Type - Cardiac AI Monitoring & Diagnostics Hardware, Cardiac AI Monitoring & Diagnostics Software and Cardiac AI Monitoring & Diagnostics Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: China 6-Year Perspective for Cardiac Artificial Intelligence Monitoring and Diagnostics by Product Type - Percentage Breakdown of Value Sales for Cardiac AI Monitoring & Diagnostics Hardware, Cardiac AI Monitoring & Diagnostics Software and Cardiac AI Monitoring & Diagnostics Services for the Years 2025 & 2030
    • TABLE 58: China Recent Past, Current & Future Analysis for Cardiac Artificial Intelligence Monitoring and Diagnostics by Application - Other Applications, Cardiac Arrhythmias Application, Stroke Application, Ischemic Heart Disease Application and Stenosis Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 59: China 6-Year Perspective for Cardiac Artificial Intelligence Monitoring and Diagnostics by Application - Percentage Breakdown of Value Sales for Other Applications, Cardiac Arrhythmias Application, Stroke Application, Ischemic Heart Disease Application and Stenosis Application for the Years 2025 & 2030
    • TABLE 60: China Recent Past, Current & Future Analysis for Cardiac Artificial Intelligence Monitoring and Diagnostics by End-Use - Hospitals End-Use, Specialty Clinics End-Use, Diagnostic Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 61: China 6-Year Perspective for Cardiac Artificial Intelligence Monitoring and Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use, Diagnostic Centers End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 62: China Recent Past, Current & Future Analysis for Cardiac Artificial Intelligence Monitoring and Diagnostics by Type - Cardiac Diagnostics and Cardiac Monitoring - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: China 6-Year Perspective for Cardiac Artificial Intelligence Monitoring and Diagnostics by Type - Percentage Breakdown of Value Sales for Cardiac Diagnostics and Cardiac Monitoring for the Years 2025 & 2030
  • EUROPE
    • Cardiac Artificial Intelligence Monitoring and Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 64: Europe Recent Past, Current & Future Analysis for Cardiac Artificial Intelligence Monitoring and Diagnostics by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 65: Europe 6-Year Perspective for Cardiac Artificial Intelligence Monitoring and Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2025 & 2030
    • TABLE 66: Europe Recent Past, Current & Future Analysis for Cardiac Artificial Intelligence Monitoring and Diagnostics by Product Type - Cardiac AI Monitoring & Diagnostics Hardware, Cardiac AI Monitoring & Diagnostics Software and Cardiac AI Monitoring & Diagnostics Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 67: Europe 6-Year Perspective for Cardiac Artificial Intelligence Monitoring and Diagnostics by Product Type - Percentage Breakdown of Value Sales for Cardiac AI Monitoring & Diagnostics Hardware, Cardiac AI Monitoring & Diagnostics Software and Cardiac AI Monitoring & Diagnostics Services for the Years 2025 & 2030
    • TABLE 68: Europe Recent Past, Current & Future Analysis for Cardiac Artificial Intelligence Monitoring and Diagnostics by Application - Other Applications, Cardiac Arrhythmias Application, Stroke Application, Ischemic Heart Disease Application and Stenosis Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Europe 6-Year Perspective for Cardiac Artificial Intelligence Monitoring and Diagnostics by Application - Percentage Breakdown of Value Sales for Other Applications, Cardiac Arrhythmias Application, Stroke Application, Ischemic Heart Disease Application and Stenosis Application for the Years 2025 & 2030
    • TABLE 70: Europe Recent Past, Current & Future Analysis for Cardiac Artificial Intelligence Monitoring and Diagnostics by End-Use - Hospitals End-Use, Specialty Clinics End-Use, Diagnostic Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 71: Europe 6-Year Perspective for Cardiac Artificial Intelligence Monitoring and Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use, Diagnostic Centers End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 72: Europe Recent Past, Current & Future Analysis for Cardiac Artificial Intelligence Monitoring and Diagnostics by Type - Cardiac Diagnostics and Cardiac Monitoring - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 73: Europe 6-Year Perspective for Cardiac Artificial Intelligence Monitoring and Diagnostics by Type - Percentage Breakdown of Value Sales for Cardiac Diagnostics and Cardiac Monitoring for the Years 2025 & 2030
  • FRANCE
    • Cardiac Artificial Intelligence Monitoring and Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 74: France Recent Past, Current & Future Analysis for Cardiac Artificial Intelligence Monitoring and Diagnostics by Product Type - Cardiac AI Monitoring & Diagnostics Hardware, Cardiac AI Monitoring & Diagnostics Software and Cardiac AI Monitoring & Diagnostics Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: France 6-Year Perspective for Cardiac Artificial Intelligence Monitoring and Diagnostics by Product Type - Percentage Breakdown of Value Sales for Cardiac AI Monitoring & Diagnostics Hardware, Cardiac AI Monitoring & Diagnostics Software and Cardiac AI Monitoring & Diagnostics Services for the Years 2025 & 2030
    • TABLE 76: France Recent Past, Current & Future Analysis for Cardiac Artificial Intelligence Monitoring and Diagnostics by Application - Other Applications, Cardiac Arrhythmias Application, Stroke Application, Ischemic Heart Disease Application and Stenosis Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 77: France 6-Year Perspective for Cardiac Artificial Intelligence Monitoring and Diagnostics by Application - Percentage Breakdown of Value Sales for Other Applications, Cardiac Arrhythmias Application, Stroke Application, Ischemic Heart Disease Application and Stenosis Application for the Years 2025 & 2030
    • TABLE 78: France Recent Past, Current & Future Analysis for Cardiac Artificial Intelligence Monitoring and Diagnostics by End-Use - Hospitals End-Use, Specialty Clinics End-Use, Diagnostic Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 79: France 6-Year Perspective for Cardiac Artificial Intelligence Monitoring and Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use, Diagnostic Centers End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 80: France Recent Past, Current & Future Analysis for Cardiac Artificial Intelligence Monitoring and Diagnostics by Type - Cardiac Diagnostics and Cardiac Monitoring - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: France 6-Year Perspective for Cardiac Artificial Intelligence Monitoring and Diagnostics by Type - Percentage Breakdown of Value Sales for Cardiac Diagnostics and Cardiac Monitoring for the Years 2025 & 2030
  • GERMANY
    • Cardiac Artificial Intelligence Monitoring and Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 82: Germany Recent Past, Current & Future Analysis for Cardiac Artificial Intelligence Monitoring and Diagnostics by Product Type - Cardiac AI Monitoring & Diagnostics Hardware, Cardiac AI Monitoring & Diagnostics Software and Cardiac AI Monitoring & Diagnostics Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 83: Germany 6-Year Perspective for Cardiac Artificial Intelligence Monitoring and Diagnostics by Product Type - Percentage Breakdown of Value Sales for Cardiac AI Monitoring & Diagnostics Hardware, Cardiac AI Monitoring & Diagnostics Software and Cardiac AI Monitoring & Diagnostics Services for the Years 2025 & 2030
    • TABLE 84: Germany Recent Past, Current & Future Analysis for Cardiac Artificial Intelligence Monitoring and Diagnostics by Application - Other Applications, Cardiac Arrhythmias Application, Stroke Application, Ischemic Heart Disease Application and Stenosis Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 85: Germany 6-Year Perspective for Cardiac Artificial Intelligence Monitoring and Diagnostics by Application - Percentage Breakdown of Value Sales for Other Applications, Cardiac Arrhythmias Application, Stroke Application, Ischemic Heart Disease Application and Stenosis Application for the Years 2025 & 2030
    • TABLE 86: Germany Recent Past, Current & Future Analysis for Cardiac Artificial Intelligence Monitoring and Diagnostics by End-Use - Hospitals End-Use, Specialty Clinics End-Use, Diagnostic Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Germany 6-Year Perspective for Cardiac Artificial Intelligence Monitoring and Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use, Diagnostic Centers End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 88: Germany Recent Past, Current & Future Analysis for Cardiac Artificial Intelligence Monitoring and Diagnostics by Type - Cardiac Diagnostics and Cardiac Monitoring - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 89: Germany 6-Year Perspective for Cardiac Artificial Intelligence Monitoring and Diagnostics by Type - Percentage Breakdown of Value Sales for Cardiac Diagnostics and Cardiac Monitoring for the Years 2025 & 2030
  • ITALY
    • TABLE 90: Italy Recent Past, Current & Future Analysis for Cardiac Artificial Intelligence Monitoring and Diagnostics by Product Type - Cardiac AI Monitoring & Diagnostics Hardware, Cardiac AI Monitoring & Diagnostics Software and Cardiac AI Monitoring & Diagnostics Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 91: Italy 6-Year Perspective for Cardiac Artificial Intelligence Monitoring and Diagnostics by Product Type - Percentage Breakdown of Value Sales for Cardiac AI Monitoring & Diagnostics Hardware, Cardiac AI Monitoring & Diagnostics Software and Cardiac AI Monitoring & Diagnostics Services for the Years 2025 & 2030
    • TABLE 92: Italy Recent Past, Current & Future Analysis for Cardiac Artificial Intelligence Monitoring and Diagnostics by Application - Other Applications, Cardiac Arrhythmias Application, Stroke Application, Ischemic Heart Disease Application and Stenosis Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Italy 6-Year Perspective for Cardiac Artificial Intelligence Monitoring and Diagnostics by Application - Percentage Breakdown of Value Sales for Other Applications, Cardiac Arrhythmias Application, Stroke Application, Ischemic Heart Disease Application and Stenosis Application for the Years 2025 & 2030
    • TABLE 94: Italy Recent Past, Current & Future Analysis for Cardiac Artificial Intelligence Monitoring and Diagnostics by End-Use - Hospitals End-Use, Specialty Clinics End-Use, Diagnostic Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 95: Italy 6-Year Perspective for Cardiac Artificial Intelligence Monitoring and Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use, Diagnostic Centers End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 96: Italy Recent Past, Current & Future Analysis for Cardiac Artificial Intelligence Monitoring and Diagnostics by Type - Cardiac Diagnostics and Cardiac Monitoring - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 97: Italy 6-Year Perspective for Cardiac Artificial Intelligence Monitoring and Diagnostics by Type - Percentage Breakdown of Value Sales for Cardiac Diagnostics and Cardiac Monitoring for the Years 2025 & 2030
  • UNITED KINGDOM
    • Cardiac Artificial Intelligence Monitoring and Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 98: UK Recent Past, Current & Future Analysis for Cardiac Artificial Intelligence Monitoring and Diagnostics by Product Type - Cardiac AI Monitoring & Diagnostics Hardware, Cardiac AI Monitoring & Diagnostics Software and Cardiac AI Monitoring & Diagnostics Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 99: UK 6-Year Perspective for Cardiac Artificial Intelligence Monitoring and Diagnostics by Product Type - Percentage Breakdown of Value Sales for Cardiac AI Monitoring & Diagnostics Hardware, Cardiac AI Monitoring & Diagnostics Software and Cardiac AI Monitoring & Diagnostics Services for the Years 2025 & 2030
    • TABLE 100: UK Recent Past, Current & Future Analysis for Cardiac Artificial Intelligence Monitoring and Diagnostics by Application - Other Applications, Cardiac Arrhythmias Application, Stroke Application, Ischemic Heart Disease Application and Stenosis Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 101: UK 6-Year Perspective for Cardiac Artificial Intelligence Monitoring and Diagnostics by Application - Percentage Breakdown of Value Sales for Other Applications, Cardiac Arrhythmias Application, Stroke Application, Ischemic Heart Disease Application and Stenosis Application for the Years 2025 & 2030
    • TABLE 102: UK Recent Past, Current & Future Analysis for Cardiac Artificial Intelligence Monitoring and Diagnostics by End-Use - Hospitals End-Use, Specialty Clinics End-Use, Diagnostic Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 103: UK 6-Year Perspective for Cardiac Artificial Intelligence Monitoring and Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use, Diagnostic Centers End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 104: UK Recent Past, Current & Future Analysis for Cardiac Artificial Intelligence Monitoring and Diagnostics by Type - Cardiac Diagnostics and Cardiac Monitoring - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 105: UK 6-Year Perspective for Cardiac Artificial Intelligence Monitoring and Diagnostics by Type - Percentage Breakdown of Value Sales for Cardiac Diagnostics and Cardiac Monitoring for the Years 2025 & 2030
  • REST OF EUROPE
    • TABLE 106: Rest of Europe Recent Past, Current & Future Analysis for Cardiac Artificial Intelligence Monitoring and Diagnostics by Product Type - Cardiac AI Monitoring & Diagnostics Hardware, Cardiac AI Monitoring & Diagnostics Software and Cardiac AI Monitoring & Diagnostics Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 107: Rest of Europe 6-Year Perspective for Cardiac Artificial Intelligence Monitoring and Diagnostics by Product Type - Percentage Breakdown of Value Sales for Cardiac AI Monitoring & Diagnostics Hardware, Cardiac AI Monitoring & Diagnostics Software and Cardiac AI Monitoring & Diagnostics Services for the Years 2025 & 2030
    • TABLE 108: Rest of Europe Recent Past, Current & Future Analysis for Cardiac Artificial Intelligence Monitoring and Diagnostics by Application - Other Applications, Cardiac Arrhythmias Application, Stroke Application, Ischemic Heart Disease Application and Stenosis Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 109: Rest of Europe 6-Year Perspective for Cardiac Artificial Intelligence Monitoring and Diagnostics by Application - Percentage Breakdown of Value Sales for Other Applications, Cardiac Arrhythmias Application, Stroke Application, Ischemic Heart Disease Application and Stenosis Application for the Years 2025 & 2030
    • TABLE 110: Rest of Europe Recent Past, Current & Future Analysis for Cardiac Artificial Intelligence Monitoring and Diagnostics by End-Use - Hospitals End-Use, Specialty Clinics End-Use, Diagnostic Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Rest of Europe 6-Year Perspective for Cardiac Artificial Intelligence Monitoring and Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use, Diagnostic Centers End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 112: Rest of Europe Recent Past, Current & Future Analysis for Cardiac Artificial Intelligence Monitoring and Diagnostics by Type - Cardiac Diagnostics and Cardiac Monitoring - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 113: Rest of Europe 6-Year Perspective for Cardiac Artificial Intelligence Monitoring and Diagnostics by Type - Percentage Breakdown of Value Sales for Cardiac Diagnostics and Cardiac Monitoring for the Years 2025 & 2030
  • ASIA-PACIFIC
    • Cardiac Artificial Intelligence Monitoring and Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 114: Asia-Pacific Recent Past, Current & Future Analysis for Cardiac Artificial Intelligence Monitoring and Diagnostics by Product Type - Cardiac AI Monitoring & Diagnostics Hardware, Cardiac AI Monitoring & Diagnostics Software and Cardiac AI Monitoring & Diagnostics Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 115: Asia-Pacific 6-Year Perspective for Cardiac Artificial Intelligence Monitoring and Diagnostics by Product Type - Percentage Breakdown of Value Sales for Cardiac AI Monitoring & Diagnostics Hardware, Cardiac AI Monitoring & Diagnostics Software and Cardiac AI Monitoring & Diagnostics Services for the Years 2025 & 2030
    • TABLE 116: Asia-Pacific Recent Past, Current & Future Analysis for Cardiac Artificial Intelligence Monitoring and Diagnostics by Application - Other Applications, Cardiac Arrhythmias Application, Stroke Application, Ischemic Heart Disease Application and Stenosis Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 117: Asia-Pacific 6-Year Perspective for Cardiac Artificial Intelligence Monitoring and Diagnostics by Application - Percentage Breakdown of Value Sales for Other Applications, Cardiac Arrhythmias Application, Stroke Application, Ischemic Heart Disease Application and Stenosis Application for the Years 2025 & 2030
    • TABLE 118: Asia-Pacific Recent Past, Current & Future Analysis for Cardiac Artificial Intelligence Monitoring and Diagnostics by End-Use - Hospitals End-Use, Specialty Clinics End-Use, Diagnostic Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 119: Asia-Pacific 6-Year Perspective for Cardiac Artificial Intelligence Monitoring and Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use, Diagnostic Centers End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 120: Asia-Pacific Recent Past, Current & Future Analysis for Cardiac Artificial Intelligence Monitoring and Diagnostics by Type - Cardiac Diagnostics and Cardiac Monitoring - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 121: Asia-Pacific 6-Year Perspective for Cardiac Artificial Intelligence Monitoring and Diagnostics by Type - Percentage Breakdown of Value Sales for Cardiac Diagnostics and Cardiac Monitoring for the Years 2025 & 2030
  • REST OF WORLD
    • TABLE 122: Rest of World Recent Past, Current & Future Analysis for Cardiac Artificial Intelligence Monitoring and Diagnostics by Product Type - Cardiac AI Monitoring & Diagnostics Hardware, Cardiac AI Monitoring & Diagnostics Software and Cardiac AI Monitoring & Diagnostics Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Rest of World 6-Year Perspective for Cardiac Artificial Intelligence Monitoring and Diagnostics by Product Type - Percentage Breakdown of Value Sales for Cardiac AI Monitoring & Diagnostics Hardware, Cardiac AI Monitoring & Diagnostics Software and Cardiac AI Monitoring & Diagnostics Services for the Years 2025 & 2030
    • TABLE 124: Rest of World Recent Past, Current & Future Analysis for Cardiac Artificial Intelligence Monitoring and Diagnostics by Application - Other Applications, Cardiac Arrhythmias Application, Stroke Application, Ischemic Heart Disease Application and Stenosis Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 125: Rest of World 6-Year Perspective for Cardiac Artificial Intelligence Monitoring and Diagnostics by Application - Percentage Breakdown of Value Sales for Other Applications, Cardiac Arrhythmias Application, Stroke Application, Ischemic Heart Disease Application and Stenosis Application for the Years 2025 & 2030
    • TABLE 126: Rest of World Recent Past, Current & Future Analysis for Cardiac Artificial Intelligence Monitoring and Diagnostics by End-Use - Hospitals End-Use, Specialty Clinics End-Use, Diagnostic Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 127: Rest of World 6-Year Perspective for Cardiac Artificial Intelligence Monitoring and Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use, Diagnostic Centers End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 128: Rest of World Recent Past, Current & Future Analysis for Cardiac Artificial Intelligence Monitoring and Diagnostics by Type - Cardiac Diagnostics and Cardiac Monitoring - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Rest of World 6-Year Perspective for Cardiac Artificial Intelligence Monitoring and Diagnostics by Type - Percentage Breakdown of Value Sales for Cardiac Diagnostics and Cardiac Monitoring for the Years 2025 & 2030

IV. COMPETITION